Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blackrock Health Sciences TrustBME -0.17%39 PS Ratio is 8.89 as of Aug. 21, 2026, which is 1% above its 10-year median of 8.79. GuruFocus rates BME with a GF Score™ of 39/100. The stock has 4 warning signs investors should review. Among 1,406 Asset Management companies, Blackrock Health Sciences Trust ranks worse than 58.46% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Blackrock Health Sciences Trust's share price is $45.72.
Blackrock Health Sciences Trust's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $5.14. Hence, Blackrock Health Sciences Trust's PS Ratio for today is 8.89.
The historical rank and industry rank for Blackrock Health Sciences Trust's PS Ratio or its related term are showing as below:
BME'
s PS Ratio Range Over the Past 10 Years
Min: 3.87 Med: 8.79 Max: 29.02
Current: 8.89
During the past 9 years, Blackrock Health Sciences Trust's highest PS Ratio was 29.02. The lowest was 3.87. And the median was 8.79.
BME's PS Ratio is ranked worse than 58.46% of 1406
companies
in the Asset Management industry
Industry Median: 7.115
vs BME: 8.89
During the past 9 years, Blackrock Health Sciences Trust's highest 3-Year average Revenue per Share Growth Rate was 22.10% per year. The lowest was -40.30% per year. And the median was -14.55% per year.
Blackrock Health Sciences Trust (NYSE:BME) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Blackrock Health Sciences Trust PS Ratio Related Terms
Blackrock Health Sciences Trust PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Blackrock Health Sciences Trust's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blackrock Health Sciences Trust PS Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Blackrock Health Sciences Trust's PS Ratio distribution charts can be found below:
* The bar in red indicates where Blackrock Health Sciences Trust's PS Ratio falls into.
Blackrock Health Sciences Trust PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Blackrock Health Sciences Trust's Share Price of today is $45.72.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Blackrock Health Sciences Trust's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $5.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Blackrock Health Sciences Trust (BME) has a PS Ratio of 8.89 as of Aug. 21, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Blackrock Health Sciences Trust and its competitors. This is near median its historical median of 8.79. Over the past decade, Blackrock Health Sciences Trust's PS Ratio has ranged from 3.87 to 29.02. According to the industry distribution chart, Blackrock Health Sciences Trust ranks #822 out of 1406 companies in the Asset Management industry, placing it in the top 58.5%.
Is Blackrock Health Sciences Trust's PS Ratio too high?
Blackrock Health Sciences Trust's current PS Ratio of 8.89 is near median its 10-year median of 8.79. Over the past 10 years, this metric has ranged from a low of 3.87 to a high of 29.02. The Asset Management industry median PS Ratio is 7.12. Blackrock Health Sciences Trust's value of 8.89 is 24.9% above this industry median. Based on the distribution chart, Blackrock Health Sciences Trust ranks #822 out of 1406 companies in the Asset Management industry, which is below the industry midpoint. Overall, Blackrock Health Sciences Trust has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Blackrock Health Sciences Trust's PS Ratio compare to MMU and ETJ?
According to the Asset Management industry distribution chart, Blackrock Health Sciences Trust ranks #822 out of 1406 companies for PS Ratio. This places Blackrock Health Sciences Trust in the lower half of its industry. The industry median PS Ratio is 7.12. Blackrock Health Sciences Trust's value of 8.89 is 24.9% above this benchmark. Historically, Blackrock Health Sciences Trust's own PS Ratio has ranged from 3.87 to 29.02 over the past decade. While the company's 10-year median is 8.79 vs. the industry median of 7.12, Blackrock Health Sciences Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for an Asset Management company?
The median PS Ratio among Asset Management companies is 7.12, based on 1,406 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blackrock Health Sciences Trust's current PS Ratio of 8.89 is 24.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Blackrock Health Sciences Trust and its competitors. For the Asset Management industry, the median PS Ratio is 7.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blackrock Health Sciences Trust's current PS Ratio is 8.89, which is near median its own 10-year median of 8.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blackrock Health Sciences Trust stock overvalued right now?
Blackrock Health Sciences Trust (BME) has a current PS Ratio of 8.89. The current PS Ratio is 8.89, which is near median its 10-year median of 8.79 and 24.9% above the Asset Management industry median of 7.12. Blackrock Health Sciences Trust's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Blackrock Health Sciences Trust (BME), the current PS Ratio is 8.89 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
39GF Score
Get the complete analysis for BME
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BME has been successfully added to your 
